{"id":22264,"date":"2022-10-06T10:34:51","date_gmt":"2022-10-06T08:34:51","guid":{"rendered":"https:\/\/idibell.cat\/?p=22264"},"modified":"2022-10-06T10:35:11","modified_gmt":"2022-10-06T08:35:11","slug":"lestimulacio-cerebral-profunda-redueix-a-la-meitat-els-simptomes-en-el-toc-sever","status":"publish","type":"post","link":"https:\/\/idibell.cat\/2022\/10\/lestimulacio-cerebral-profunda-redueix-a-la-meitat-els-simptomes-en-el-toc-sever\/","title":{"rendered":"L\u2019estimulaci\u00f3 cerebral profunda redueix a la meitat els s\u00edmptomes en el TOC sever"},"content":{"rendered":"

Aproximadament una de cada deu persones que pateix Trastorn Obsessiu-Compulsiu (TOC) presenta una forma cr\u00f2nica i incapacitant de la malaltia. Aquests casos m\u00e9s severs s\u00f3n resistents als tractaments convencionals -psicoter\u00e0pia i f\u00e0rmacs- i comporten gran patiment tant a pacients com a fam\u00edlia. En els darrers anys, l’estimulaci\u00f3 cerebral profunda ha comen\u00e7at a estudiar-se com a alternativa terap\u00e8utica per aquests pacients. Un equip multidisciplinari de l\u2019Hospital Universitari de Bellvitge (HUB) i l\u2019IDIBELL ha confirmat que aquesta \u00e9s una t\u00e8cnica segura i efectiva, amb una reducci\u00f3 dels s\u00edmptomes obsessius en un 42,5% a llarg termini.<\/p>\n

Fins ara, el coneixement dels efectes a llarg termini d\u2019aquesta opci\u00f3 terap\u00e8utica eren molt limitats. El cap de Servei de Psiquiatra de l\u2019HUB i cap de grup de l\u2019IDIBELL, Jos\u00e9 Manuel Mench\u00f3n, coordina el grup del CIBERSAM de l\u2019Institut de Salut Carlos III (ISCIII), que ha estudiat la segona mostra de pacients de TOC resistent tractada amb estimulaci\u00f3 cerebral profunda m\u00e9s nombrosa al m\u00f3n. El seu equip, ubicat a Bellvitge, ha determinat que aquesta opci\u00f3 terap\u00e8utica \u00e9s una alternativa segura i efica\u00e7 a curt i llarg termini.<\/p>\n

 <\/p>\n

Qu\u00e8 \u00e9s l\u2019estimulaci\u00f3 cerebral profunda? <\/strong><\/h4>\n

Es tracta d\u2019un tractament quir\u00fargic que consisteix en implantar uns el\u00e8ctrodes que permeten estimular el\u00e8ctricament punts espec\u00edfics del cervell, de forma selectiva i reversible, aconseguint beneficis terap\u00e8utics en malalties resistents a tractaments, com la malaltia de Parkinson, la tremolor essencial, la distonia o l\u2019epil\u00e8psia. Els Serveis de Psiquiatria i Neurocirurgia de l\u2019HUB van iniciar el programa de tractament amb estimulaci\u00f3 cerebral profunda per a pacients amb TOC resistent i sever al 2007.<\/p>\n

L\u2019equip multidisciplinari de l\u2019IDIBELL ha estudiat l\u2019evoluci\u00f3 de pacients tractats en aquest centre hospitalari entre 2007 i 2020 durant una mitjana de 6,4 anys i els han comparat amb un grup de pacients obsessius severs i resistents, als que es va oferir la possibilitat de rebre estimulaci\u00f3 cerebral profunda, per\u00f2 la van rebutjar. Els resultats, publicats a la revista cient\u00edfica Brain Stimulation<\/em><\/a>, determinen que, a m\u00e9s de reduir els s\u00edmptomes obsessius, l\u2019estimulaci\u00f3 cerebral profunda tamb\u00e9 ha incidit en una millora de l\u2019ansietat i la depressi\u00f3 en aquests pacients i una recuperaci\u00f3 significativa de la seva capacitat funcional.<\/p>\n

L\u2019estudi ha comprovat, a m\u00e9s, que pocs pacients experimenten efectes adversos i que la majoria d\u2019aquests s\u00f3n lleus i transitoris.<\/p>\n

 <\/p>\n

 <\/p>\n

L\u2019Institut d’Investigaci\u00f3 Biom\u00e8dica de Bellvitge (IDIBELL) \u00e9s un centre de recerca en biomedicina creat l\u2019any 2004. Est\u00e0 participat per l’Hospital Universitari de Bellvitge i l\u2019Hospital de Viladecans de l’Institut Catal\u00e0 de la Salut, l’Institut Catal\u00e0 d’Oncologia, la Universitat de Barcelona i l\u2019Ajuntament de l\u2019Hospitalet de Llobregat.<\/em><\/p>\n

L\u2019IDIBELL \u00e9s membre del Campus d’Excel\u00b7l\u00e8ncia Internacional de la Universitat de Barcelona HUBc i forma part de la instituci\u00f3 CERCA de la Generalitat de Catalunya. L’any 2009 es va convertir en un dels cinc primers centres d\u2019investigaci\u00f3 espanyols acreditats com a institut d\u2019investigaci\u00f3 sanit\u00e0ria per l\u2019Instituto de Salud Carlos III. A m\u00e9s, forma part del programa \u201cHR Excellence in Research\u201d de la Uni\u00f3 Europea i \u00e9s membre de EATRIS i REGIC. Des de l\u2019any 2018, l\u2019IDIBELL \u00e9s un Centro Acreditado de la Fundaci\u00f3n Cient\u00edfica AECC (FCAECC).<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"

Ho han comprovat a partir de l\u2019estudi de l\u2019evoluci\u00f3 de la segona mostra de pacients m\u00e9s nombrosa al m\u00f3n, tractats i seguits per un equip multidisciplinari a Bellvitge des de l\u2019inici del programa el 2007<\/p>\n","protected":false},"author":8,"featured_media":22265,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"footnotes":""},"categories":[340,457,429],"tags":[],"publishpress_future_action":{"enabled":false,"date":"2024-05-11 16:45:55","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"_links":{"self":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/22264"}],"collection":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/comments?post=22264"}],"version-history":[{"count":1,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/22264\/revisions"}],"predecessor-version":[{"id":22266,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/22264\/revisions\/22266"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media\/22265"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media?parent=22264"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/categories?post=22264"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/tags?post=22264"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}